Aarkstore - Healthcare Market Access Czech Republic

1
Healthcare Market Access Czech Republic
Aarkstore.com
2
Summary

• The report provides in-depth information ono
  Country Landscape This section covers
  information on the prevailing economic
  environment in the country. The GDP per capita
  has improved indicating trends in the economic
  indicators and improvement. The demographic
  profile of the country indicates that a majority
  of the population is in the economically
  productive age group.o Healthcare
  infrastructure Insightful review of the
  countrys healthcare system and health status
  with key health indicators are presented in this
  section. Moreover, healthcare expenditure and
  major healthcare providers are mentioned. The
  profiles of major hospitals and the number of
  healthcare personnel in the country are also
  covered.o Overview of Pharmaceutical Market
  This section depicts the pharmaceutical market in
  terms of size, growth, product mix and key
  players operating in the country. A special
  emphasis has been laid on the key drivers and
  barriers impacting the pharmaceutical market of
  the country. Furthermore, major diseases with
  high burden for the country have been covered. 

3
Summary

• Key questions answered in this report The
  report answers majority of key questions that are
  paramount for the success of a pharmaceutical
  company such as How stable is the countrys
  political climate, major economic indices like
  GDP size and growth, rate of inflation, FDI, etc.
  impacting the level of business sentiments How
  lucrative is the pharmaceutical market of the
  country in terms of size, growth, product
  portfolio mix, key market segments and the level
  of competitive intensity  Who are the relevant
  stakeholders that needs to be engaged effectively
  for successful product commercialization What
  are the key trends and policies that may impact
  the future market access landscape and how to
  effectively counter them Which are the
  cost-containment measures that have been adopted
  by the countrys government and may be introduced
  in the near future Which are the major disease
  segments that a pharmaceutical company can focus
  for product launch and growth based on the
  disease burden in the country What are the key
  policies that impacts the pricing and
  reimbursement decisions in both public and
  private sector Whether the countrys
  pharmaceutical market represents a compelling
  commercial case to invest and offers significant
  opportunities that can be successfully tapped
  resulting in significant revenue generation

4
Summary

• Key benefits / Why should you buy this
  reportAs every countrys market access
  landscape is unique and evolving, it makes a
  prudent decision to have a country specific
  market access strategy. Moreover, the success of
  any pharmaceutical company hinges on successfully
  navigating challenges posed by the various
  stakeholders and regulatory bodies for effective
  product commercialization. This report will
  serve as a handy tool for pharmaceutical and
  other related healthcare stakeholders to
  Understand the macro and micro parameters that
  will play a pivotal role in making business
  decisions Identify, target and collaborate with
  the relevant stakeholders that hold key to
  effective product commercialization
  Conceptualize and formulate plausible market
  access strategies based on the insights
  generated  Identify and foresee the major
  trends and policies likely to impact the
  regulatory, pricing and reimbursement landscape
  of the country Capitalize on the opportunities
  presented by the countrys pharmaceutical market
  and mitigate the challenges posed by the
  competitors and stakeholders/regulatory bodies

5
Table of Content

1. EXECUTIVE SUMMARY 6
2. COUNTRY LANDSCAPE 7
3. OVERVIEW OF THE PHARMACEUTICAL MARKET 13
4. HEALTHCARE INFRASTRUCTURE 17
5. MARKET ACCESS 27
6. CONCLUSION 32
7. APPENDIX 33

6
List of Tables

• Table 1 Economic indicators in the Czech
  Republic 9Table 2 Demographic breakdown of
  Czech Republic based on 2014 estimates 11Table
  3 Types of medicine distribution to the network
  of healthcare facilities in Q1 2012 14Table 4
  Access to safe drinking water and sanitation
  (2012 estimates) 19Table 5 Healthcare
  indicators of Czech Republic 20Table 6
  Healthcare personnel in Czech Republic 27

7
List of Figures

• Figure 1 Distribution of medicines in financial
  figures and number of packages in the Czech
  Republic 13Figure 2 Financial flow in the Czech
  Republic 22Figure 3 Expenditure on health
  services by sources of financing 23Figure 4
  Number of physicians per 1000 population in the
  Czech Republic and selected countries 27Figure
  5 Organizational Structure of the Czech
  healthcare system 29

Browse full report Or Sample Request
_at_ http//www.aarkstore.com/pharmaceuticals-health
care/117426/healthcare-market-access-czech-republi
c
8
Related Reports

• Global Cephalosporin Drugs Industry 2015 Market
  Research Report
• Europe Remifentanil Hydrochloride Industry Report
  2015
• 2015 Gelatin Capsule Industry Report - Global and
  Chinese Market
• Global Herbal Supplements and Remedies Industry
  2015 Market Research Report
• Global Cephalosporin Drugs Industry 2015 Market
  Research Report
• Europe Remifentanil Hydrochloride Industry Report
  2015

9
Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
10
Contact Us
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953